SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001587221-19-000006
Filing Date
2019-03-25
Accepted
2019-03-25 08:59:56
Documents
78
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K q4fy1810k.htm 10-K 2106171
2 EXHIBIT 23.1 q4fy18ex231.htm EX-23.1 2756
3 EXHIBIT 31.1 q4fy18ex311.htm EX-31.1 15012
4 EXHIBIT 31.2 q4fy18ex312.htm EX-31.2 13513
5 EXHIBIT 32.1 q4fy18ex321.htm EX-32.1 18682
12 zotriptrialresultsa01.jpg GRAPHIC 85134
  Complete submission text file 0001587221-19-000006.txt   8723910

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT zsan-20181231.xml EX-101.INS 1524868
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20181231.xsd EX-101.SCH 65488
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20181231_cal.xml EX-101.CAL 92686
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20181231_def.xml EX-101.DEF 332190
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20181231_lab.xml EX-101.LAB 878293
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20181231_pre.xml EX-101.PRE 516868
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36570 | Film No.: 19701425
SIC: 2834 Pharmaceutical Preparations